November 2025 in “npj Breast Cancer” In this study of women with breast cancer undergoing chemotherapy and scalp cooling, 12% experienced incomplete hair regrowth at 6 months, with tamoxifen therapy identified as a significant risk factor for persistent chemotherapy-induced alopecia.
October 2025 in “EMJ Dermatology” This study found that glucagon-like peptide-1 receptor agonist therapy was independently associated with an increased incidence of non-scarring hair loss, including telogen effluvium and androgenic alopecia, in adults but not alopecia areata.
September 2025 in “JAAD reviews.” In this systematic review and meta-analysis, researchers evaluated the link between alopecia areata and adverse pregnancy outcomes, motivated by the condition's association with other autoimmune diseases that increase pregnancy risks. Results are not provided in the abstract.
August 2025 in “Figshare” This meta-analysis found that patients with alopecia areata, especially those with alopecia totalis or alopecia universalis, have an increased risk of cardiovascular disease, possibly due to shared immunological mechanisms and systemic inflammation. Further research is needed to confirm these findings and explore underlying mechanisms.
July 2025 in “Malaysian Journal of Medicine and Health Sciences” This study found that individuals with alopecia areata in Malaysian tertiary hospitals who are unmarried and have diabetes are more likely to experience a poorer quality of life, based on their Dermatology Life Quality Index scores.
June 2025 in “Frontiers in Neurology” This study found a significant association between finasteride use and increased risk of memory impairment, highlighting the need for risk communication and routine cognitive monitoring for long-term users.
May 2025 in “Nutrition and Diabetes” This study found that elevated 1-hour plasma glucose in women with PCOS was associated with increased risk of metabolic disorders and gestational diabetes, indicating it may be a useful marker for adverse metabolic status.
May 2025 in “Australasian Journal of Dermatology” In this observational study, researchers reported a significant association between COVID-19 infection or vaccination and the development of new-onset lichen planus, suggesting these events, particularly infection, may act as triggers for the condition.
January 2025 in “Pakistan Journal of Health Sciences” This study found a weak association between Cyp11a1 gene variation and polycystic ovary syndrome, with higher di-hydro-testosterone levels observed in individuals with the syndrome and anovulatory PCOS compared to controls.
January 2025 in “Nutrients” In this study, researchers found that specific genetic variations at loci rs1160312, rs6113491, and rs1041668 are independent risk factors for androgenetic alopecia in men, and these risks can be influenced by diet.
January 2025 in “Japanese Journal of Gastroenterology and Hepatology” This study found that non-alcoholic fatty liver disease was prevalent among women with polycystic ovarian syndrome and was linked to higher BMI, waist/hip ratio, testosterone levels, and deranged lipid profile.
December 2024 in “JEADV Clinical Practice” This study found that male patients with androgenetic alopecia were associated with an increased risk of varicose veins, but not other major vascular diseases.
December 2024 in “Journal of General-Procedural Dermatology & Venereology Indonesia” This study found that telogen effluvium was significantly more common among women who wear hijabs compared to those who do not in the observed Indonesian population.
November 2024 in “Journal of Investigative Dermatology” Polygenic Score can help predict severe psoriasis and psoriatic arthritis.
November 2024 in “The Journal of Dermatology” This study found that atopic diseases such as atopic dermatitis, asthma, and allergic rhinitis increase the risk of developing alopecia areata, suggesting a significant role for T cell-related inflammation in the condition's mechanism.
September 2024 in “Journal of Cosmetic Dermatology” This study examined the FDA Adverse Event Reporting System database and found significant associations between low-dose oral minoxidil use and adverse events like pericardial effusion, highlighting the need for caution and recommending the use of the lowest effective dose until more safety data are available.
September 2024 in “Medicina” This study found that among women with PCOS, the FokI CC genotype of the VDR gene may offer protection against acne and seborrhea, while the VDR-TaqI dominant genotype is associated with reduced oxidative stress.
September 2024 in “Cutis” Sunscreen use may increase the risk of frontal fibrosing alopecia.
September 2024 in “Journal of the American Academy of Dermatology” Sun-protective behaviors increased, and sunburns decreased in both Hispanic and Non-Hispanic White individuals from 2005 to 2020.
July 2024 in “Journal of Investigative Dermatology” Treating gastrointestinal issues can reduce rosacea flares, and treating rosacea can lower gastrointestinal problems.
June 2024 in “Current Developments in Nutrition” This population-based study found that n-3 fatty acid intake may not benefit and could potentially harm hair loss improvement in middle-aged or elderly men, as higher n-3 intake was associated with a greater risk of non-improvement in male pattern hair loss.
June 2024 in “Deleted Journal” This study found that women in China who consumed sugar-sweetened beverages more than seven times per week had a higher risk of experiencing hair loss, and anxiety may mediate this link.
May 2024 in “Skin appendage disorders” The authors concluded that articles on androgenetic alopecia with high Altmetric Attention Scores were more frequently cited, indicating that social media influence is linked to academic impact.
May 2024 in “Medicine today” In this hospital-based case-control study, researchers at Bangabandhu Sheikh Mujib Medical University found that age, family history of alopecia, and low serum ferritin levels may be significant risk factors for female pattern hair loss among the studied population.
April 2024 in “Proceedings” This study found a significant association between alopecia areata and low serum ferritin levels, suggesting that assessing and correcting iron stores might improve alopecia areata management.
This review explores the risk factors, associated comorbidities, and psychological impacts of early-onset androgenetic alopecia, highlighting its complexity and potential implications for treatment response and overall health.
February 2024 in “Clinical, Cosmetic and Investigational Dermatology” This study reports a solid causal relationship between increased serum levels of ApoB, LDL, and VLDL and an elevated risk of androgenic alopecia.
January 2024 in “Hypertension research” More research is needed to understand sex and racial differences in long COVID.
January 2024 in “Frontiers in endocrinology” This study found that genetic variants linked to hypothyroidism significantly increased the risk of developing alopecia areata, suggesting a causative connection between the two conditions.
September 2023 in “JEADV Clinical Practice” This study reviewed existing literature and found that androgenic alopecia may be associated with cardiovascular risk factors, while evidence for alopecia areata and cicatricial alopecias is limited and sometimes contradictory.